MicroRNAs regulate protein synthesis by binding non-translated regions of mRNAs and suppressing translation and/or increasing mRNA degradation. MicroRNAs play an important role in the nervous system including controlling synaptic plasticity. Their expression is altered in disease states including stroke, head injury and epilepsy. To better understand microRNA expression changes that might contribute to the development of epilepsy, microRNA arrays were performed on rat hippocampus 4 hours, 48 hours and 3 weeks following an episode of pilocarpine induced status epilepticus. Eighty microRNAs increased at one or more of the time points. No microRNAs decreased at 4 hours, and only a few decreased at 3 weeks, but 188 decreased 48 hours after status epilepticus. The large number of microRNAs with altered expression following status epilepticus suggests that microRNA regulation of translation has the potential to contribute to changes in protein expression during epileptogenesis. We carried out a second set of array’s comparing microRNA expression at 48 hours in synaptoneurosome and nuclear fractions of the hippocampus. In control rat hippocampi multiple microRNAs were enriched in the synaptoneurosomal fraction as compared to the nuclear fraction. In contrast, 48 hours after status epilepticus only one microRNA was enriched in the synaptoneurosome fraction. The loss of microRNAs enriched in the synaptoneurosomal fraction implies a dramatic change in translational regulation in synapses 48 hours after status epilepticus.
Citation: Risbud RM, Porter BE (2013) Changes in MicroRNA Expression in the Whole Hippocampus and Hippocampal Synaptoneurosome Fraction following Pilocarpine Induced Status Epilepticus. PLoS ONE 8(1): e53464. doi:10.1371/journal.pone.0053464
Editor: Cesar V. Borlongan, University of South Florida, United States of America
Received: October 11, 2012; Accepted: November 30, 2012; Published: January 7, 2013
Copyright: © 2013 Risbud, Porter. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: NINDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Epilepsy is a common disorder effecting up to 1% of the population, with one-third of patients having seizures that are refractory to medications. There currently are no treatments aimed at preventing the development of epilepsy. Molecular changes contributing to the development of epilepsy are under intense study in the hopes of identifying therapeutic targets for preventing epilepsy. Inducing a prolonged seizure in rodents, status epilepticus (SE), is a model for studying epileptogenesis; as the animals eventually go on to develop spontaneous seizures. Hopefully, in the future studies of epileptogenesis in rodents can lead to pharmacologic interventions targeting specific pathways for preventing epilepsy in humans.
MicroRNAs regulate protein production by binding to the 3′ end of mRNAs and blocking translation and/or increasing degradation. A microRNA may have hundreds of unique mRNAs targets making altered expression of a single microRNA capable of regulating multiple cellular pathways. Changes have been identified in microRNA expression in multiple neurologic diseases including stroke, head trauma and epilepsy , , , , , , , . A recent study has suggested that suppression of microRNA 138 can diminish the severity of kainite induced SE . MicroRNA function can be manipulated by injection of mimics or antagomirs making them potential therapeutic targets for the treatment or prevention of epilepsy.
Using a variety of techniques several labs have shown that microRNAs are present in dendrites and a subset are highly enriched in dendrites , , . While a few microRNAs present at the synapse have been implicated in regulating synaptic plasticity, the function of most microRNAs in the brain have not been determined , , , , , .
Status epilepticus has been shown to cause destruction and loss of synaptic boutons that to some extent recover once the ongoing seizure activity resolves , . Chronically, there are changes in dendrite complexity in the hippocampus of humans and animals with epilepsy , . The mechanisms for synaptic bouton and dendrite changes during SE and chronically in epilepsy are not known, though glutamate receptor activation with calcium influx has been proposed as a possible mechanism . How changes in microRNA expression might be contributing to changes in synaptic plasticity or dendrite injury following SE has not been studied.
Here we measure changes in microRNA expression in whole hippocampal samples and in subcellular fractionated samples of the hippocampus following pilocarpine induced SE. There are multiple microRNAs that change following SE and the pool of synaptoneurosome enriched microRNAs diminishes 48 hours after SE.
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The Institutional Animal Care and Use Committee of the Children’s Hospital of Philadelphia approved the experimental protocol.
Induction of SE
Adult male CD (sprague-dawley) rats from Charles River between 60 to 90 days of age underwent pilocarpine induced SE. All animals received methyl-scopolamine, 1 mg/kg intraperitoneal (IP) 30 minutes prior to the pilocarpine injection to block peripheral cholinergic effects. Status epilepticus was induced with pilocarpine (385 mg/kg, IP), with a half dose given 1 hour later if a Racine stage V, tonic clonic, seizure did not occur . Control rats received, 1/10th dose or 38.5 mg/kg of pilocarpine IP to partially control for pilocarpine effects. The SE rats were monitored for appearance of stage V racine seizures, and received a dose of valium 6 mg/kg IP 1 hour after induction of a stage V seizure. If the animal was still having behavioral seizures 2 hours after the first dose of valium it recieved 3 mg/kg dose of valium every 2 hours as needed until the behavioral seizures resolved. Control animals receive valium doses similar to the SE group to control for the effects of valium.
Rats were sacrificed 4 hours, 48 hours, and 3 weeks after the induction of SE. Rats were anesthetized with isoflurane and hippocampal tissue was dissected out and fast frozen, sonicated and RNA extracted using the mirVANA miRNA isolation kit (Ambion Inc., Austin, Texas, USA). The quality and quantity of RNA are assessed on the Agilent Bioanalyzer for presence of 5, 5.8, 18S bands.
An Exicon 10.2 array (Exicon,Denmark) was carried out following the companies protocol. Two micrograms of total hippocampal RNA from 4 hour, 48 hour and 3 week control and SE treated animals was labeled with Cy3 or Cy5 aminoallyl tailing to make the fluorescent probes using the Exicon labeling kit. We took a dye swap approach, a control-Cy3 and seizure-Cy5 sample was probed on an array then the same samples with the dyes switched, seizure-Cy3 and control-Cy5 were probed on an array , . This was done for control and SE animals at each time point. Similarly, for the synaptoneurosome and nuclear fraction array studies, a nuclear-Cy3 and a synaptoneurosome-Cy5 sample was probed on an array then the same samples with the dyes switched, synaptoneurosome-Cy5 and a nuclear-Cy3 was probed on an array. A t-test was performed for microRNAs expressed above background.
Preparation of Synaptoneurosome Fraction and Nuclear Pellet
Hippocampal synaptoneurosomes were prepared as originally described , . All steps were conducted on ice or 4°C, and all solutions were made using diethylpyrocarbonate-treated and nuclease-free water. Briefly, hippocampi were gently homogenized at 4°C in 10 times volume of isolation media (0.32 M sucrose, 10 mM Tris-HCl, 1 mM EDTA). After a low speed centrifugation step to remove cell bodies, the resulting supernatant was centrifuged at 12,500 RPM for 20 min using a Beckman JA-17 rotor. The resulting pellet was gently suspended in a small volume of isolation media and then brought with 12% Ficoll in a total volume of 5.5 ml. After layering 3 mL of 7% Ficoll over this solution, followed by 3.3 mL of isolation media, the samples underwent ultracentrifugation at 27,000 RPM for 30 min using a Beckman SW-41ti rotor. Synaptoneurosomes were isolated at the 7%/12% interface and washed four times (10 mL per wash) in isolation media. One aliquot of this material was analyzed for protein using the BCA protein assay kit (Pierce, Rockford, IL.). A second aliquot was diluted in 2X SDS sample buffer. We showed that these synaptosoneurosomes contain virtually no histone H3, suggesting that they are relatively free of cell bodies .
Specific stem loop miRNA primers from the Taqman MicroRNA Assays and reagents from the Reverse Transcription Kit (Applied Biosystems) were used to transcribe miR 124, 103, 30c, 128a, 138, 21, 21*, Let 7b and 4.5 s. Concentrations of RNA and cDNA were measured using a spectrophotometer (ND 1000, Thermo Fischer Scientific Inc, Wilmington, DE). Reactions were carried out in 384-well plates with 5 µl of the Taqman Universal PCR Master Mix (Applied Biosystems, Branchburg, NJ), 0.5 µl of the probe/primer mix for either the gene of interest, 2.5 µl of ddH2O, and 2 µl of sample DNA per well. Concentrations of DNA were diluted so that approximately 1000ηg–1100ηg of sample DNA were added to each well. Each sample was run in two sets of triplicates, the No AmpErase UNG (Applied Biosystems) enzyme was used (Applied Biosystems) with one set with the probe for the gene of interest and one for 4.5S ribonuclear small RNA. A standard curve for each probe was included on each plate using cDNA from the cortex of a control rat. The real-time PCR assays were carried out on a SDS 7900HT model thermocycler (Applied Biosystems). The real-time PCR settings were 50°C for 2 minutes, 95°C for 10 minutes, and then 40 cycles of 95°C for 1 minutes and 60°C for 1 minute. The housekeeping genes, 4.5 s for the hippocampus samples did not vary across treatment group for any of the time points.
Reverse transcription using random hexamers was performed using a Superscript II Reverse Transcription kit for mRNAs (Invitrogen, Carlsbad, California, USA). Reactions were carried out in 384-well plates with 5 µl of the Taqman Universal PCR Master Mix (Applied Biosystems, Branchburg, NJ), 0.5 µl of the probe/primer mix for either the gene of interest HDAC3 (Rn00584926_m1), GAPDH (Rn01775763_g1), CAMK2α (Rn00563883_m1), DLGAP2 also known as PSD95/SAP90, (Rn00588099_m1), GRIA2 also known as GLUR2 (Rn00568514_m1), MTAP2 also known as MAP2 (Rn00565046_m1) 2.5 ul of ddH2O, and 2 µl of sample DNA per well. Concentrations of cDNA were diluted so that approximately 1000 ηg–1100ηg of sample cDNA were added to each well. Each sample was run in two sets of triplicates, one set with the probe for the gene of interest and one for PPIA, cyclophilin. A standard curve for each probe was included on each plate using cDNA from the cortex of a control rat.
Rats were sacrificed at 4 hours, 48 hours and 3 weeks, following pilocarpine induced SE, encompassing the time period over which most of the rats will develop chronic epilepsy. Typically, using this model rats developed epilepsy by 8–15 days after SE , , . To identify microRNAs that change after SE, MicroRNA array analysis on whole hippocampus was performed. Table 1 displays microRNAs that increased following SE; Table 2 displays microRNAs that increased at one time point and decreased at another time point; and Table 3 are microRNAs that only decreased following SE. Four hours after SE using a t-test cutoff <0.05, there is an increase in 67 microRNAs and none that decreased (Figure 1 and Tables 1, and 2). Forty-eight hours after SE 10 microRNAs increased, and 188 decreased (Figure 1 and Table 2 and 3). By three weeks after SE there were 33 microRNAs that increased, and 3 that decreased, (Figure 1 Table 1, 2, and 3).
There are a large number of microRNAs that specifically decreased at 48 hours after SE. The specific microRNAs that change are listed on Tables 1, 2 and 3. We used a P value of 0.05 on a t-test to identify microRNAs that change.
To determine if the microRNA changes identified on the array could be validated using a second technique, real-time PCR was carried out on hippocampus samples at 48 hours after SE (Figure 2). Of eight microRNAs tested six of the eight had a difference in the direction identified on the array. Let-7b trended downward similar to the array, but was not significantly lower. MiR138 had decreased on the array but no difference was found in its level by real time PCR, with a trend toward an increased level.
P*<0.05 T-test, control N = 8 to 9 and SE N = 7 to 9 samples per group.
Prior studies found that microRNAs are prominently expressed in dendrites in vitro and a subset of microRNAs are enriched in synaptoneurosomes of the cortex and hippocampus , , . Subcellular fractionation of the hippocampus was performed to determine if there was a redistribution of microRNAs from the synaptoneurosome pool following SE. Multiple microRNAs were found to be enriched in the synaptoneurosome fraction in the control animals, i.e. a synaptoneurosome/nuclear ratio >1, see Figure 3A. Forty-eight hours after SE microRNAs were not enriched in the synaptoneurosome fraction. Table 4 lists the synaptoneurosome/nuclear ratio of each microRNA from the most highly synaptoneurosome enriched to the lowest, in control animals and 48 hours after SE. In Figure 3B the control synaptoneurosome/nuclear ratios, highest to lowest, are plotted with an x; the o directly below the X is the synaptoneurosome/nuclear ratio of the same microRNA 48 hours after SE. There is a dramatic reduction in the highly enriched synaptoneurosome/nuclear microRNAs 48 hours after SE.
A) A dot plot of the synaptoneurosome/nuclear ratio of all of the microRNAs expressed above background in at least four arrays from either nuclear or synaptoneurosome fractions. MicroRNAs in the hippocampus of control animals and 48 hours after SE are plotted with the mean and standard error shown by black lines. B) The synaptoneurosome/nuclear ratio of all of the microRNAs expressed above background are plotted left to right, based on the microRNAs that are most highly enriched to the least in the synaptoneurosome fraction in the control hippocampus. X represents the synaptoneurosome/nuclear microRNA ratio of the control samples, and directly below each X the 0 is the same microRNAs synaptoneurosome/nuclear ratio of the SE samples. Specific microRNAs and their synaptoneurosome/nuclear microRNA ratio are shown in Table 4. We have highlighted in red a subset of microRNAs that have previously been shown to be enriched in dendrites or synaptoneurosomes and highlighted in green a subset of microRNAs that have previously been shown to be expressed at low levels in dendrites or synaptoneurosomes , , .
The microRNAs shown in red on Figure 3b have previously been reported as dendritic or synaptoneurosome enriched. , , . The microRNAs shown in green on Figure 3b have been previously reported to have low levels of expression in dendrites or synaptoneurosomes , , . MicroRNA expression in the hippocampal synaptoneurosomes and nuclear fractions from the control animals were mostly consistent with the findings in prior studies.
Of the microRNAs present on the synaptoneurosome/nuclear fraction arrays, 100 were also microRNAs that were identified as decreased in the whole hippocampal sample 48 hours post SE. These are bolded and highlighted in yellow on Table 4. Eighty-four of the 100 were synaptoneurosome enriched in the control hippocampus, synaptoneurosome/nuclear >1. Five were equally distributed between the synaptoneurosome and nuclear fractions, synaptoneurosome/nuclear ∼1. Eleven were nuclear enriched, synaptoneurosome/nuclear<1.
To assess our ability to fractionate nuclear and synaptoneurosome RNA we used real time PCR to measure two mRNAs that had previously been shown to be enriched in the nuclear fraction, histone deacetylase three (HDAC3) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) . GAPDH mRNA was enriched in the nuclear fraction from the hippocampus of the control and the SE treated animals. (Figure 4, N = 6 for all groups; control nuclear-0.5±0.14, synaptoneurosome-0.09±0.02; SE nuclear-0.3±0.03, synaptoneurosome-0.08±0.03, mean±SEM, **P<0.01 Mann-Whitney). HDAC3 mRNA was not enriched in the nuclear fraction of the control animals (Figure 4, N = 6 for all groups; control nuclear-0.44±0.07, synaptoneurosome-0.24±0.03, mean±SEM, P = 0.06 Mann-Whitney). HDAC3 mRNA was enriched in the nuclear fraction of the SE animals (Figure 4, N = 6 for all groups; SE nuclear-0.53±0.03, synaptoneurosome-0.28±0.06, mean±SEM, **P<0.01 Mann-Whitney) Forty-eight hours after SE, HDAC3 and GAPDH mRNA levels did not change significantly in the nuclear or synaptoneurosome fractions.
N = 6 for all samples, Nuclear control (nuc-ctl), synaptoneurosome control (syn-ctl), Nuclear SE (nuc-sz), synaptoneurosome SE (syn-sz), P**<0.01 Mann-Whitney.
We next used real time PCR to measure the levels in the nuclear and synaptoneurosome fractions of 4 mRNAs previously identified as expressed in dendrites: Ca++/calmodulin dependant protein kinase IIα (CAMK2α), GLUR2 subunit of the α-amino-3hydroxy-5-methyl-4-isocazolepropionic acid (AMPA) receptor (GRIA2), post-synaptic density gaunylate kinase (DLGAP2), and microtubule associated protein 2 (MTAP2) (Figure 5). All 4 mRNAs were present in the synaptoneurosome fraction and three were present in equal abundance in the synaptoneurosome and nuclear fractions, only MTAP2 was enriched in the synaptoneurosome fraction (N = 6 for all groups, control nuclear-0.06±0.01 and synaptoneurosome-0.14±0.02, mean±SEM P***<0.01 Mann-Whitney). The data suggest that HDAC3 and GAPDH mRNAs are nuclear enriched and while the four mRNAs (CAMK2α, GRIA2, DLGAP2, MTAP2) are highly expressed in the synaptoneurosome fraction, only MTAP2 mRNA was enriched.
MTAP3 mRNA levels are similar in synaptoneurosome and nuclear fractions 48 hours after SE. CAMK2α, GRIA2 and DLGAP2 mRNA as measured by real-time PCR was similar in the synaptoneurosome and nuclear fractions of both control and SE animal’s hippocampi. Following SE CAMK2α and DLGAP2 mRNA decreased in both the nuclear and synaptoneurosome fractions, P * 0.05, P** 0.01, P*** 0.001 ANOVA with Bonferroni corrections N = 6 for all samples, nuclear control (nuc-ctl), synaptoneurosome control (syn-ctl), nuclear SE (nuc-sz), synaptoneurosome SE (syn-sz).
To determine if there is a decrease in the synaptoneurosome/nuclear ratio of mRNAs 48 hours after SE, similar to the reduction in microRNAs; CAMK2α, GRIA2, DLGAP2, and MTAP2 mRNA levels were compared in the synaptoneurosome and nuclear fractions of controls and SE treated animals. CAMK2α and DLGAP2 mRNA levels decreased in both the nuclear and synaptoneurosome fractions 48 hours after SE (N = 6 for all groups, CAMK2α: control nuclear-0.30±0.03, SE nuclear −0.12±0.05, mean±SEM, P*<0.05 ANOVA with Bonferroni corrections; control synaptoneurosome −0.37±0.05 mean±SEM, SE synaptoneurosome −0.11±0.08 mean±SEM P**<0.01 ANOVA with Bonferroni multiple corrections; DLGAP2: control nuclear fraction −0.15±0.03, mean±SEM, SE nuclear fraction 0.03±0.01, mean±SEM, P***<0.0001 ANOVA with Bonferroni corrections; control synaptoneurosome fraction −0.08±0.01 mean±SEM, SE synaptoneurosome fraction −0.01±0.004 mean±SEM P*<0.05 ANOVA with Bonferroni multiple corrections). The MTAP2 mRNA enrichment in synaptoneurosomes seen in controls was not present following SE. This was at least partially due to increased MTAP2 mRNA in the nuclear sample following SE (N = 6 for all groups mean±SEM, Control nuclear −0.063±0.01, Control synaptoneurosome −0.144±0.02, SE nuclear −0.13±0.06, SE synaptoneurosome −0.10±0.02). GRIA2 mRNA levels were unchanged in both the nuclear and synaptoneurosome fractions following SE. Following SE the synaptoneurosome/nuclear ratio of CAMK2α, GRIA2 and DLGAP2 mRNAs did not change. There was, however, a decrease in the synaptoneurosome/nuclear ratio of MTAP2 mRNA but this was accompanied by an increase in nuclear MTAP2 mRNA levels 48 hours after SE.
Here we show that following SE a subset of microRNAs increase at 4 hours, 48 hours and 3 weeks following SE. At the first time point we studied, 4 hours post-SE no microRNAs decreased. Forty-eight hours after SE however, 188 microRNAs decreased and by 3 weeks after SE only three microRNAs had decreased. The very specific decrease in 188 microRNAs only at 48 hours after SE suggests either a simultaneous decrease in production or increased degradation of a large number of microRNAs at a specific period of time following SE.
To begin to understand the mechanism underlying the decrease in microRNAs at 48 hours we carried out subcellular fractionation of the hippocampus and measured the synaptoneurosome/nuclear ratio of microRNAs following SE. Similar to prior studies we found a large pool of microRNAs enriched in the synaptoneurosome fraction compared to the nuclear fraction of the control hippocampus . Forty-eight hours after SE there were almost no synaptoneurosome enriched microRNAs. The decrease in microRNAs in the whole hippocampal sample correlates with a decrease in the synaptoneurosome/nuclear microRNA ratio. The decrease in the synaptoneurosome/nuclear ratio 48 hours after SE would be consistent with either a reduction in microRNA levels in the synaptoneurosomes, a shift of microRNAs from the synaptoneurosome to nuclear fraction or an increased microRNA levels in the nuclear fraction. While a shift of microRNAs from the synaptoneurosome to the nuclear fraction or an increase in microRNA in the nuclear fraction could explain the reduction in the synaptoneurosome/nuclear ratio it would be inconsistent with the large number of microRNAs that decreased at 48 hours in the whole hippocampal samples.
MicroRNA expression can be regulated at multiple steps including transcription, post-transcriptional processing and degradation of mature microRNAs , . The half-lives of mature microRNAs vary greatly over minutes to weeks with most being days to weeks . In culture altering the cellular density can shorten the half-lives of some microRNAs from days to less than an hour . Neuronal activity in vitro and in vivo can trigger increased degradation of microRNAs . Our finding of multiple decreased microRNAs at 48 hours after SE would be consistent with a shorter half-life for some microRNAs after SE, but future studies in vivo would be needed to confirm this finding. Taken together our current hypothesis is that decreases in the overall levels of microRNAs 48 hours after SE are related to a reduction in synaptoneurosome microRNAs due to increased degradation. Future studies are being directed at tagging microRNAs to measure processing, subcellular targeting and degradation following SE to better understand the mechanism of microRNA loss 48 hours after SE.
We used a low threshold for identifying changes in microRNAs following SE on the arrays, t-test less than 0.05. We were able to validate changes in 6 of 8 microRNAs using real time PCR at 48 hours after SE. Suggesting that many but certainly not all of the microRNA changes we identified on the arrays following SE are independent of the technique.
Prior studies in epilepsy models have identified a variety of microRNAs that change following SE , , , , . None of them, however, used an identical epilepsy model, microRNA measurement platforms or time points as the present study making cross study comparisons difficult. All of the array studies identified a subset of microRNAs that increased and a subset that decreased. Only a small subset of the microRNAs they identified as changing after seizures also changed in our study and the four previously published studies had few microRNA changes in common. Four of the five studies, including ours, identified an increase in miR132 . Three studies, including ours identified an increase in mir21, and a decrease in miR98. No other microRNA changes were identified in more than two studies, suggesting a great deal of heterogeneity and time course specific changes in microRNAs following a seizure.
The finding of an abundance of microRNAs enriched in the synaptoneurosome of the hippocampus is similar to a prior study of synaptoneurosomes from mouse forebrain . Of the 20 most highly synaptoneurosome enriched microRNAs in the Lugli et al. 2008 paper four were also enriched in our hippocampal synaptoneurosomes (shown in red on Figure 3). Of the 10 microRNAs enriched in the nuclear fraction in their study five were nuclear enriched in our study (shown in green on Figure 3B) and three trended toward nuclear enrichment. Another study using laser capture to isolate dendrites and nuclear samples from hippocampal cultures identified five microRNAs that were in greater concentrations in the dendrites than cell bodies, of these two were enriched in our synaptoneurosome fraction (shown in red on Figure 3b) . A more recent study using array and confirmed with real-time PCR identified three microRNAsas synaptoneurosome and three nuclear enriched in the cortex. All six microRNAs were similarly enriched in our hippocampal samples from control animals. There is a large pool of microRNAs present in the synaptoneurosome fraction and a subset appears to be highly enriched.
A prolonged seizure causes swelling, blebbing and loss of normal dendritic architecture , . The mechanism of this dendritic damage is not clear though the changes are most severe during the seizure with some recovery post seizure. In the present study the rats had strong seizure activity, stage III-V Racine scale, for an hour prior to receiving valium. While none of these animals underwent VEEG recording it is likely the seizure activity was subsiding by 4 hours. By 48 hours they look relatively well and if having seizure they showed minimal behavioral signs. If the decrease we see in microRNAs at 48 hours were due to a direct loss of synaptic boutons that probably would have been most severe at 4 hours post SE. Instead we suspect, though do not prove, that there was an increase in the rates of microRNA degradation in the synaptoneurosome fraction following SE.
The lack of a change in the synaptoneursome/nuclear ratio of CAMK2α, GRIA2, and DLGAP2, 48 hours after SE suggests that the change in microRNAs synaptoneursome/nuclear ratio might be specific to microRNAs and not due to a global effect on RNA. To prove this further studies focused on the mechanism of the microRNA loss are needed.
Previous studies found a specific loss of GRIA2 mRNA in the CA3 pyramidal cell layer which we did not find in the fractionated whole hippocampus . The decrease in CAMK2α mRNA in both the nuclear and synaptoneurosome fractions following SE may be contributing to the development of epilepsy as transgenic mice lacking CAMK2α are epileptic . Prior studies in vitro and in vivo suggest that CAMK2α activity is down regulated in multiple seizure models, however, not due to a decrease in the level of the CAMK2α protein , , . Further studies to understand the cause of the decrease in CAMK2α mRNA, its effect on CAMK2α activity and how it contributes to epileptogenesis may be warranted.
Local mRNA translation in dendrites plays an important role in the regulation of synapse structures and functions. Activity dependent regulation of synapse stability via mRNA translation in dendrites appears to be partially mediated by a subset of microRNAs , , . Our finding that an episode of SE causes a decrease in synaptoneurosome microRNAs suggests that SE could disrupt the ability of synapses to respond to normal activity cues. Future studies to better understand the mechanism and the implications for loss of synaptoneurosome microRNAs following SE will have implications for epileptogenesis and learning and memory impairment in epilepsy.
We thank Drs. Eric Marsh and Paulette McRae for helpful discussions and editing of the paper.
Conceived and designed the experiments: RMR BEP. Performed the experiments: RMR BEP. Analyzed the data: RMR BEP. Wrote the paper: BEP.
- 1. Redell JB, Liu Y, Dash PK (2009) Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes. J Neurosci Res 87: 1435–1448.
- 2. Redell JB, Zhao J, Dash PK (2011) Altered expression of miRNA-21 and its targets in the hippocampus after traumatic brain injury. J Neurosci Res 89: 212–221.
- 3. Aronica E, Fluiter K, Iyer A, Zurolo E, Vreijling J, et al. (2010) Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 31: 1100–1107.
- 4. Hu K, Zhang C, Long L, Long X, Feng L, et al. (2011) Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus. Neurosci Lett 488: 252–257.
- 5. Song YJ, Tian XB, Zhang S, Zhang YX, Li X, et al. (2011) Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b. Brain Res 1387: 134–140.
- 6. Jimenez-Mateos EM, Bray I, Sanz-Rodriguez A, Engel T, McKiernan RC, et al. (2011) miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132. Am J Pathol 179: 2519–2532.
- 7. Risbud RM, Lee C, Porter BE (2011) Neurotrophin-3 mRNA a putative target of miR21 following status epilepticus. Brain Res 1424: 53–59.
- 8. Sano T, Reynolds JP, Jimenez-Mateos EM, Matsushima S, Taki W, et al. (2012) MicroRNA-34a upregulation during seizure-induced neuronal death. Cell Death Dis 3: e287.
- 9. Jimenez-Mateos EM, Engel T, Merino-Serrais P, McKiernan RC, Tanaka K, et al. (2012) Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med 18: 1087–1094.
- 10. Lugli G, Torvik VI, Larson J, Smalheiser NR (2008) Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain. J Neurochem 106: 650–661.
- 11. Kye MJ, Liu T, Levy SF, Xu NL, Groves BB, et al. (2007) Somatodendritic microRNAs identified by laser capture and multiplex RT-PCR. RNA 13: 1224–1234.
- 12. Cougot N, Bhattacharyya SN, Tapia-Arancibia L, Bordonne R, Filipowicz W, et al. (2008) Dendrites of mammalian neurons contain specialized P-body-like structures that respond to neuronal activation. J Neurosci 28: 13793–13804.
- 13. Lambert TJ, Storm DR, Sullivan JM (2010) MicroRNA132 modulates short-term synaptic plasticity but not basal release probability in hippocampal neurons. PLoS One 5: e15182.
- 14. Lippi G, Steinert JR, Marczylo EL, D’Oro S, Fiore R, et al. (2011) Targeting of the Arpc3 actin nucleation factor by miR-29a/b regulates dendritic spine morphology. J Cell Biol 194: 889–904.
- 15. Lee K, Kim JH, Kwon OB, An K, Ryu J, et al. (2012) An activity-regulated microRNA, miR-188, controls dendritic plasticity and synaptic transmission by downregulating neuropilin-2. J Neurosci 32: 5678–5687.
- 16. Siegel G, Obernosterer G, Fiore R, Oehmen M, Bicker S, et al. (2009) A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol 11: 705–716.
- 17. Wayman GA, Davare M, Ando H, Fortin D, Varlamova O, et al. (2008) An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci U S A 105: 9093–9098.
- 18. Vo N, Klein ME, Varlamova O, Keller DM, Yamamoto T, et al. (2005) A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A 102: 16426–16431.
- 19. Guo D, Arnspiger S, Rensing NR, Wong M (2012) Brief seizures cause dendritic injury. Neurobiol Dis 45: 348–355.
- 20. Zeng LH, Xu L, Rensing NR, Sinatra PM, Rothman SM, et al. (2007) Kainate seizures cause acute dendritic injury and actin depolymerization in vivo. J Neurosci 27: 11604–11613.
- 21. Swann JW, Al-Noori S, Jiang M, Lee CL (2000) Spine loss and other dendritic abnormalities in epilepsy. Hippocampus 10: 617–625.
- 22. Multani P, Myers RH, Blume HW, Schomer DL, Sotrel A (1994) Neocortical dendritic pathology in human partial epilepsy: a quantitative Golgi study. Epilepsia 35: 728–736.
- 23. Wong M, Guo D (2012) Dendritic spine pathology in epilepsy: Cause or consequence? Neuroscience.
- 24. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281–294.
- 25. Tsai CA, Chen YJ, Chen JJ (2003) Testing for differentially expressed genes with microarray data. Nucleic Acids Res 31: e52.
- 26. Altman N (2005) Replication, variation and normalisation in microarray experiments. Appl Bioinformatics 4: 33–44.
- 27. Booth RF, Clark JB (1978) A method for the rapid separation of cytosolic and particulate components of rat brain synaptosomes, proceedings. Biochem Soc Trans 6: 128–129.
- 28. Glanzer J, Miyashiro KY, Sul JY, Barrett L, Belt B, et al. (2005) RNA splicing capability of live neuronal dendrites. Proc Natl Acad Sci U S A 102: 16859–16864.
- 29. Ross JR, Ramakrishnan H, Porter BE, Robinson MB (2011) Group I mGluR-regulated translation of the neuronal glutamate transporter, excitatory amino acid carrier 1. J Neurochem 117: 812–823.
- 30. Mello LE, Cavalheiro EA, Tan AM, Kupfer WR, Pretorius JK, et al. (1993) Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34: 985–995.
- 31. Raol YH, Lund IV, Bandyopadhyay S, Zhang G, Roberts DS, et al. (2006) Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. J Neurosci 26: 11342–11346.
- 32. Pichardo-Casas I, Goff LA, Swerdel MR, Athie A, Davila J, et al. (2012) Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulation. Brain Res 1436: 20–33.
- 33. Poon MM, Choi SH, Jamieson CA, Geschwind DH, Martin KC (2006) Identification of process-localized mRNAs from cultured rodent hippocampal neurons. J Neurosci 26: 13390–13399.
- 34. Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597–610.
- 35. Krol J, Busskamp V, Markiewicz I, Stadler MB, Ribi S, et al. (2010) Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 141: 618–631.
- 36. Bail S, Swerdel M, Liu H, Jiao X, Goff LA, et al. (2010) Differential regulation of microRNA stability. RNA 16: 1032–1039.
- 37. Kim YK, Yeo J, Ha M, Kim B, Kim VN (2011) Cell adhesion-dependent control of microRNA decay. Mol Cell 43: 1005–1014.
- 38. Liu DZ, Tian Y, Ander BP, Xu H, Stamova BS, et al. (2010) Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 30: 92–101.
- 39. McKiernan RC, Jimenez-Mateos EM, Sano T, Bray I, Stallings RL, et al. (2012) Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death. Exp Neurol 237: 346–354.
- 40. Rensing N, Ouyang Y, Yang XF, Yamada KA, Rothman SM, et al. (2005) In vivo imaging of dendritic spines during electrographic seizures. Ann Neurol 58: 888–898.
- 41. Huang Y, Doherty JJ, Dingledine R (2002) Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. J Neurosci 22: 8422–8428.
- 42. Butler LS, Silva AJ, Abeliovich A, Watanabe Y, Tonegawa S, et al. (1995) Limbic epilepsy in transgenic mice carrying a Ca2+/calmodulin-dependent kinase II alpha-subunit mutation. Proc Natl Acad Sci U S A 92: 6852–6855.
- 43. Blair RE, Churn SB, Sombati S, Lou JK, DeLorenzo RJ (1999) Long-lasting decrease in neuronal Ca2+/calmodulin-dependent protein kinase II activity in a hippocampal neuronal culture model of spontaneous recurrent seizures. Brain Res 851: 54–65.
- 44. Blair RE, Sombati S, Churn SB, Delorenzo RJ (2008) Epileptogenesis causes an N-methyl-d-aspartate receptor/Ca2+-dependent decrease in Ca2+/calmodulin-dependent protein kinase II activity in a hippocampal neuronal culture model of spontaneous recurrent epileptiform discharges. Eur J Pharmacol 588: 64–71.
- 45. Churn SB, Kochan LD, DeLorenzo RJ (2000) Chronic inhibition of Ca(2+)/calmodulin kinase II activity in the pilocarpine model of epilepsy. Brain Res 875: 66–77.
- 46. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, et al. (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439: 283–289.
- 47. Ceman S, Saugstad J (2011) MicroRNAs: Meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human disease. Pharmacol Ther 130: 26–37.